PROSTIN E2 Rx

Select the drug indication to add to your list

PROSTIN E2

Miscellaneous Ob/Gyn conditions
Only 4 drugs may be compared at once

Generic Name and Formulations:

Dinoprostone 20mg; per vaginal suppository.

Company:

Pfizer Inc.

Select therapeutic use:

Indications for PROSTIN E2:

For the termination of pregnancy from the 12th through the 20th gestational weeks. For the evacuation of the uterine contents in the management of missed abortion or intrauterine fetal death up to 28 weeks of gestational age. Management of nonmetastatic gestational trophoblastic disease (benign hydatidiform mole).

Adult:

Insert one supp high into vagina. Remain in supine position for 10 minutes following insertion. May insert subsequent supp at 3–5 hour intervals until abortion occurs. Continuous administration for more than 2 days is not recommended.

Children:

Not applicable.

Contraindications:

Acute pelvic inflammatory disease. Active cardiac, pulmonary, renal or hepatic disease.

Warnings/Precautions:

Should only be used by trained medical professional in a hospital setting. Not indicated if fetus in utero has reached the stage of viability. Not for use in cervical ripening or other indication in patients with term pregnancy. Asthma. Hypo-or hypertension. Anemia. Jaundice. Diabetes. Epilepsy. Cervicitis. Infected endocervical lesions. Acute vaginitis. Compromised (scarred) uteri. Pregnancy (Cat.C).

Interactions:

Concomitant other oxytocic agents: not recommended.

Pharmacological Class:

Prostaglandin E2.

Adverse Reactions:

Vomiting, transient pyrexia (see literature re: PGEs induced pyrexia vs. endometritis pyrexia), diarrhea, nausea, headache, chills, transient decrease in BP; MI in patients with history of cardiovascular disease.

How Supplied:

Supps—5